Next events
6th EORTC Quality of Life in Cancer Clinical Trials Conference
May 12, 2025 - May 13, 2025
Barcelona, Spain
36th EORTC-NCI-AACR Symposium
October 23 - October 25
Barcelona, Spain
Clinical Trial Statistics for Non-Statisticians
June 11 - June 14
Brussels, BE
14th European Breast Cancer Conference (EBCC-14)
March 20 - March 22
Milan, Italy
Interested To Learn More About Cancer Research?
On 30 & 31 October 2024, EORTC organises a training course aiming to provide you with a stimulating and challenging experience leading to a much better understanding of cancer research.
A two-day training course for cancer patients, caregivers, and patient advocates
The course program has been co-developed together with patient partners of EORTC.
The course will be conducted in English and is aimed for cancer patients, caregivers of cancer patients, family members, patient advocates, and patient representatives.
It will give you an opportunity to interact with clinical oncologists and other people with lived experience of cancer.
Programme
Wednesday, 30 October 2024
After learning more about the formation of cancer cells, you will have an opportunity to look into the work of pathologist. The second session will unravel the approaches of different specialists to cancer treatment, including the quality of life aspects.
Thursday, 31 October 2024
Day 2 will give you insights into the concepts of randomisation and blinding. Real-world data and HTA sessions will be followed by a panel discussion of patient advocates and patient organisations.
The detailed programme can be consulted below.
CANCER BIOLOGY AND TREATMENT | |
13:00 – 13:05 | Welcome and introduction |
13:05 – 13:15 | Setting the scene Speaker: Iryna Shakhnenko |
13:15 – 13:35 | What causes a cell to become cancerous? Speaker: Gianmarco Contino |
13:35 – 13:55 | Role of pathologist & what happens after the biopsy Speaker: Roberto Salgado |
13:55 – 14:15 | Clinical impact of new molecular techniques Speaker: Marie Morfouace |
14:15 – 14:35 | Precision medicine and personalized treatment Speaker: Anne-Marie Dingemans |
14:35 – 14:50 | Q&A |
14:50 – 15:05 | Coffee break |
MULTIDISCIPLINARY APPROACH TO CANCER TREATMENT | |
15:05 – 15:25 | Latest advancements in radiation oncology Speaker: Matthias Guckenberger |
15:25 – 15:45 | Role of surgery in combination with immunotherapy Speaker: Frederieke van Duijnhoven |
15:45 – 16:05 | Quality of life during and after cancer treatments Speaker: Alexandra Gilbert |
16:05 – 16:25 | Q&A |
16:25 – 16:40 | Panel discussion |
16:40 | Closing remarks |
CLINICAL TRIALS | |
13:00 – 13:05 | Welcome & Introduction Speaker: Iryna Shakhnenko |
13:05 – 13:25 | Objectives and endpoints in oncology trials & patient involvement Speaker: Winette van der Graaf |
13:25 – 13:45 | Randomization, blinding, and placebo: what stands behind it Speaker: Catherine Fortpied |
13:45 – 13:55 | Q&A Speaker: Iryna Shakhnenko |
13:55 – 14:15 | Pragmatic trials & RWD Speaker: Fabio Borges |
14:15 – 14:35 | Health technology assessment: what it means for the patient Speaker: François Houÿez |
14:35 – 14:45 | Q&A |
14:45 – 15:00 | Patient preferences of and perspectives about data protection and data control Speaker: Teodora Lalova-Spinks |
15:00 – 15:05 | Q&A |
15:05 – 15:15 | Coffee break |
CANCER, LIFESTYLE, AND PATIENT PERSPECTIVE | |
15:15 – 15:35 | Exercise throughout the breast cancer care continuum Speaker: Antonio Di Meglio |
15:35 – 15:55 | Exercise and physical activity: physical and psychological effects in prostate cancer Speaker: Louis Fox |
15:55 – 16:25 | Patient organizations: their impact on clinical research Speaker: Iryna Shakhnenko |
16:25 – 16:35 | Q&A |
16:35 – 16:55 | Panel discussion |
16:55 | Closing remarks |
Our faculty
The EORTC Patient Days Programme Committee is composed of experienced patient advocates whose mission is to encourage education for cancer patients and their family members, as well as to increase public awareness and understanding of clinical research.
In this role, the Committee members were supported by the EORTC HQ staff members and directors.
Leading oncologists and researchers from different European countries will share their expertise and experience in cancer treatments and research and offer their insights on the impact of lifestyle on cancer. In an interactive session, patient partners will provide views on the role of patient organizations as key stakeholders in oncology research.